Clinical Trial Update: Pemetrexed-free vs. Pemetrexed-based Immunochemotherapy in Metastatic TTF-1 Negative Lung Adenocarcinoma [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing pemetrexed-free versus pemetrexed-based immunochemotherapy in metastatic TTF-1 negative lung adenocarcinoma, a subset of non-sm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma
• Non-small Cell Lung Cancer

Drugs mentioned

• Pemetrexed (pemetrexed)

Snippet

Sponsor: Nikolaj Frost MD | Conditions: Non-Small Cell Lung Cancer Metastatic | Phase 4 | Status: ACTIVE_NOT_RECRUITING